AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 36 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $406,000 | -29.0% | 172,187 | -18.9% | 0.01% | -25.0% |
| Q1 2019 | $572,000 | -1.0% | 212,197 | -20.7% | 0.01% | -20.0% |
| Q4 2018 | $578,000 | -22.6% | 267,544 | +5.0% | 0.02% | -6.2% |
| Q3 2018 | $747,000 | +149.8% | 254,799 | +105.6% | 0.02% | +166.7% |
| Q2 2018 | $299,000 | -54.0% | 123,926 | +168.5% | 0.01% | -57.1% |
| Q1 2018 | $650,000 | +55.1% | 46,163 | +31.1% | 0.01% | +55.6% |
| Q4 2017 | $419,000 | – | 35,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
| Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
| Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
| Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
| DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
| UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
| Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
| DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
| Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |